BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 33248856)

  • 21. Nonsyndromic Peripheral Pulmonary Artery Stenosis Is Associated With Homozygosity of RNF213 p.Arg4810Lys Regardless of Co-occurrence of Moyamoya Disease.
    Chang SA; Song JS; Park TK; Yang JH; Kwon WC; Kim SR; Kim SM; Cha J; Jang SY; Cho YS; Kim TJ; Bang OY; Song JY; Ki CS; Kim DK
    Chest; 2018 Feb; 153(2):404-413. PubMed ID: 28962888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differing disease phenotypes of Duchenne muscular dystrophy and Moyamoya disease in female siblings of a Korean family.
    Park J; Jang W; Han JY
    Mol Genet Genomic Med; 2019 Sep; 7(9):e862. PubMed ID: 31347299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency of the moyamoya-related RNF213 p.Arg4810Lys variant in 1,516 Korean individuals.
    Jang MA; Shin S; Yoon JH; Ki CS
    BMC Med Genet; 2015 Nov; 16():109. PubMed ID: 26590131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Familial moyamoya disease in two Turkish siblings with same polymorphism in RNF213 gene but different clinical features.
    Bayram AK; Yilmaz E; Per H; Ito M; Uchino H; Doganay S; Houkin K; Unal E
    Childs Nerv Syst; 2016 Mar; 32(3):569-73. PubMed ID: 26277359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Germline gain-of-function mutations in AFF4 cause a developmental syndrome functionally linking the super elongation complex and cohesin.
    Izumi K; Nakato R; Zhang Z; Edmondson AC; Noon S; Dulik MC; Rajagopalan R; Venditti CP; Gripp K; Samanich J; Zackai EH; Deardorff MA; Clark D; Allen JL; Dorsett D; Misulovin Z; Komata M; Bando M; Kaur M; Katou Y; Shirahige K; Krantz ID
    Nat Genet; 2015 Apr; 47(4):338-44. PubMed ID: 25730767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. De novo variants in RNF213 are associated with a clinical spectrum ranging from Leigh syndrome to early-onset stroke.
    Brunet T; Zott B; Lieftüchter V; Lenz D; Schmidt A; Peters P; Kopajtich R; Zaddach M; Zimmermann H; Hüning I; Ballhausen D; Staufner C; Bianzano A; Hughes J; Taylor RW; McFarland R; Devlin A; Mihaljević M; Barišić N; Rohlfs M; Wilfling S; Sondheimer N; Hewson S; Marinakis NM; Kosma K; Traeger-Synodinos J; Elbracht M; Begemann M; Trepels-Kottek S; Hasan D; Scala M; Capra V; Zara F; van der Ven AT; Driemeyer J; Apitz C; Krämer J; Strong A; Hakonarson H; Watson D; Mayr JA; Prokisch H; Meitinger T; Borggraefe I; Spiegler J; Baric I; Paolini M; Gerstl L; Wagner M
    Genet Med; 2024 Feb; 26(2):101013. PubMed ID: 37924258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and Molecular Features of 5 European Multigenerational Families With Moyamoya Angiopathy.
    Grangeon L; Guey S; Schwitalla JC; Bergametti F; Arnould M; Corpechot M; Hadjadj J; Riant F; Aloui C; Drunat S; Vidaud D; Tournier-Lasserve E; Kraemer M
    Stroke; 2019 Apr; 50(4):789-796. PubMed ID: 30908154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poor outcomes in carriers of the RNF213 variant (p.Arg4810Lys) with pulmonary arterial hypertension.
    Hiraide T; Kataoka M; Suzuki H; Aimi Y; Chiba T; Isobe S; Katsumata Y; Goto S; Kanekura K; Yamada Y; Moriyama H; Kitakata H; Endo J; Yuasa S; Arai Y; Hirose N; Satoh T; Hakamata Y; Sano M; Gamou S; Kosaki K; Fukuda K
    J Heart Lung Transplant; 2020 Feb; 39(2):103-112. PubMed ID: 31542298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic Validation of RNF213 Coding Variants in Japanese Patients With Moyamoya Disease.
    Moteki Y; Onda H; Kasuya H; Yoneyama T; Okada Y; Hirota K; Mukawa M; Nariai T; Mitani S; Akagawa H
    J Am Heart Assoc; 2015 May; 4(5):. PubMed ID: 25964206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic Disorders in Prenatal Onset Syndromic Short Stature Identified by Exome Sequencing.
    Homma TK; Freire BL; Honjo Kawahira RS; Dauber A; Funari MFA; Lerario AM; Nishi MY; Albuquerque EV; Vasques GA; Collett-Solberg PF; Miura Sugayama SM; Bertola DR; Kim CA; Arnhold IJP; Malaquias AC; Jorge AAL
    J Pediatr; 2019 Dec; 215():192-198. PubMed ID: 31630891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RNF213 p.R4810K Variant and Intracranial Arterial Stenosis or Occlusion in Relatives of Patients with Moyamoya Disease.
    Matsuda Y; Mineharu Y; Kimura M; Takagi Y; Kobayashi H; Hitomi T; Harada KH; Uchihashi Y; Funaki T; Miyamoto S; Koizumi A
    J Stroke Cerebrovasc Dis; 2017 Aug; 26(8):1841-1847. PubMed ID: 28506590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RNF213 variant in a patient with Legius syndrome associated with moyamoya syndrome.
    Romanisio G; Chelleri C; Scala M; Piccolo G; Carlini B; Gatti L; Capra V; Zara F; Bersano A; Pavanello M; De Marco P; Diana MC
    Mol Genet Genomic Med; 2021 Jun; 9(6):e1669. PubMed ID: 33939317
    [No Abstract]   [Full Text] [Related]  

  • 33. A new horizon of moyamoya disease and associated health risks explored through RNF213.
    Koizumi A; Kobayashi H; Hitomi T; Harada KH; Habu T; Youssefian S
    Environ Health Prev Med; 2016 Mar; 21(2):55-70. PubMed ID: 26662949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic Analysis of RNF213 c.14576G>A Variant in Nonatherosclerotic Quasi-Moyamoya Disease.
    Miyawaki S; Imai H; Shimizu M; Yagi S; Ono H; Nakatomi H; Shimizu T; Saito N
    J Stroke Cerebrovasc Dis; 2015 May; 24(5):1075-9. PubMed ID: 25817623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Posterior circulation involvement and collateral flow pattern in moyamoya disease with the RNF213 polymorphism.
    Kim WH; Kim SD; Nam MH; Jung JM; Jin SW; Ha SK; Lim DJ; Lee HB
    Childs Nerv Syst; 2019 Feb; 35(2):309-314. PubMed ID: 30283986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular tortuosity of the internal carotid artery is related to the RNF213 c.14429G > A variant in moyamoya disease.
    An S; Kim T; Oh CW; Bang JS; Lee SU; Heo J
    Sci Rep; 2019 Jun; 9(1):8614. PubMed ID: 31197213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sibling cases of moyamoya disease having homozygous and heterozygous c.14576G>A variant in RNF213 showed varying clinical course and severity.
    Miyatake S; Touho H; Miyake N; Ohba C; Doi H; Saitsu H; Taguri M; Morita S; Matsumoto N
    J Hum Genet; 2012 Dec; 57(12):804-6. PubMed ID: 22931863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exome Sequencing Identified CCER2 as a Novel Candidate Gene for Moyamoya Disease.
    Mukawa M; Nariai T; Onda H; Yoneyama T; Aihara Y; Hirota K; Kudo T; Sumita K; Maehara T; Kawamata T; Kasuya H; Akagawa H
    J Stroke Cerebrovasc Dis; 2017 Jan; 26(1):150-161. PubMed ID: 27717682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Case of Familial Moyamoya Disease Presenting 10 Years After Initial Negative Magnetic Resonance Screening in Childhood.
    Aoyama J; Nariai T; Mukawa M; Inaji M; Tanaka Y; Maehara T
    World Neurosurg; 2017 Sep; 105():1035.e1-1035.e4. PubMed ID: 28619492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significant Association of the RNF213 p.R4810K Polymorphism with Quasi-Moyamoya Disease.
    Morimoto T; Mineharu Y; Kobayashi H; Harada KH; Funaki T; Takagi Y; Sakai N; Miyamoto S; Koizumi A
    J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2632-2636. PubMed ID: 27476341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.